Clinical Trials on Plasma Caffeine Concentration in Ireland
Total 100 results
-
University of LimerickIrish Research CouncilCompletedAttention Concentration DifficultyIreland
-
Cancer Trials IrelandCompleted
-
PepsiCo Global R&DCompletedMicrobiome | Plasma Cholesterol | PrebioticIreland
-
National University of Ireland, Galway, IrelandJanssen Pharmaceuticals; Cancer Trials IrelandUnknownMultiple MyelomaIreland
-
West of Scotland Lymphoma GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
University College CorkCancer Research@UCCRecruiting
-
Cancer Trials IrelandBristol-Myers Squibb; Janssen PharmaceuticalsActive, not recruiting
-
Cancer Trials IrelandSanofi; Dana-Farber Cancer InstituteRecruitingMultiple MyelomaDenmark, Ireland
-
Landspitali University HospitalMemorial Sloan Kettering Cancer Center; Celgene; Amgen; University of IcelandEnrolling by invitationMultiple Myeloma | Smoldering Multiple MyelomaIceland
-
University of IcelandMemorial Sloan Kettering Cancer Center; Landspitali University Hospital; deCODE... and other collaboratorsActive, not recruitingMonoclonal Gammopathy of Undetermined SignificanceIceland
-
Cancer Trials IrelandCompleted
-
Janssen Research & Development, LLCNo longer availableRelapsed or Refractory Multiple MyelomaBelgium, Iceland, Portugal, Slovenia
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
Leeds Cancer Centre at St. James's University HospitalUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
GlycoMimetics IncorporatedCompletedMultiple MyelomaIreland, Denmark, United Kingdom, Germany
-
University of GlasgowCompletedRenal Failure | Multiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
John L. ReaganThe Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode IslandActive, not recruiting
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Urinary Complications | Breast Adenocarcinoma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | Metastatic Malignant Neoplasm to the Bone | Musculoskeletal ComplicationUnited States, Puerto Rico
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Spectrum Pharmaceuticals, IncCompletedLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, B-Cell, Marginal Zone | Waldenstrom Macroglobulinemia | Lymphoma, Small-CellUnited States
-
NovartisCompletedMultiple MyelomaCanada, United States, Australia, Taiwan, Ireland
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.CompletedMultiple MyelomaNorway, Sweden, Denmark, Finland, Iceland
-
PfizerBristol-Myers SquibbRecruiting
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Aronex PharmaceuticalsCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Infection | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States, Puerto Rico
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
CelgeneCompletedMultiple MyelomaNetherlands, Spain, Belgium, Austria, Switzerland, Italy, Germany, France, Ireland, United Kingdom, Denmark, Finland, Portugal, Turkey, Poland, Estonia, Greece, Norway, Slovakia, Sweden
-
Tarix PharmaceuticalsConstant Therapeutics LLCTerminatedLymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin DiseaseUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
PfizerAvailableMultiple MyelomaUnited States, Canada
-
PfizerCompletedMultiple MyelomaCanada, United States
-
PfizerRecruitingMultiple MyelomaUnited States, Canada
-
CelgeneCompletedMultiple MyelomaSpain, United Kingdom, Switzerland, Australia, Israel, Italy, Poland, France, Belgium, Ireland, Austria, Germany, Ukraine, Greece, Sweden
-
GlaxoSmithKlineIqvia Pty LtdActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
AbbVieCompletedMultiple Myeloma (MM)United States, Argentina, Australia, Brazil, Canada, Croatia, Czechia, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Norway, Poland, Romania, Saudi Arabia, Slovenia, Spain, Taiwan, Turkey
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Fatigue | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Hoffmann-La RocheCompleted
-
AEterna ZentarisDana-Farber Cancer InstituteTerminatedMultiple MyelomaIsrael, Spain, Korea, Republic of, United States, Russian Federation, Canada, Ireland, Czechia, Slovakia
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Canada, Spain, Israel, United Kingdom, Germany, Austria, Belgium, France, Italy, Ireland, Netherlands, Sweden
-
AbbVieTerminatedCancer | Multiple Myeloma (MM)United States, Australia, France, Israel, Japan, Spain, Taiwan